Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sclerosis, Multiple”

3,780 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,780 results

Large-scale testing (Phase 3)Study completedNCT01201356
What this trial is testing

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 4,125
Post-approval studies (Phase 4)Study completedNCT00220922
What this trial is testing

Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.

Who this might be right for
Multiple Sclerosis
Teva Neuroscience, Inc. 50
Not applicableStudy completedNCT04538872
What this trial is testing

Learning Strategies for Improving Dual Task Performance in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hasselt University 37
Not applicableStudy completedNCT00336557
What this trial is testing

Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 1,230
Not applicableEnded earlyNCT03647722
What this trial is testing

Assessing the Induction of Long-term Immune Regulation Following Treatment With Lemtrada® (Alemtuzumab).

Who this might be right for
Multiple Sclerosis
University of Southern California 97
Not applicableStudy completedNCT02651545
What this trial is testing

Effects of Teriflunomide (Aubagio) on Cognitive and Vocational Outcomes in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
State University of New York at Buffalo 60
Large-scale testing (Phase 3)Ended earlyNCT01416181
What this trial is testing

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Biogen 889
Not applicableStudy completedNCT01195857
What this trial is testing

Assessment of Subject Use of the Rebiject II Injection Device According to Nurse Examination of Subject Accuracy in 10 Steps as a Dummy Demonstration

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 100
Early research (Phase 1)Study completedNCT01031901
What this trial is testing

Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)

Who this might be right for
Tuberous SclerosisNeurofibromatosesAngiofibroma+1 more
The University of Texas Health Science Center, Houston 52
Not applicableStudy completedNCT05757830
What this trial is testing

PURO - PUlmonary Rehabilitation With O-RAGT Platform

Who this might be right for
Multiple SclerosisSpinal Cord InjuryStroke+1 more
Fondazione Don Carlo Gnocchi Onlus 20
Early research (Phase 1)Study completedNCT01803867
What this trial is testing

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Acorda Therapeutics 72
Not applicableLooking for participantsNCT04873492
What this trial is testing

From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Nantes University Hospital 130
Early research (Phase 1)Ended earlyNCT01028209
What this trial is testing

Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions

Who this might be right for
Alzheimer DiseaseParkinson DiseaseMultiple Sclerosis
Institute for Neurodegenerative Disorders 12
Very early researchStudy completedNCT05357833
What this trial is testing

Novel Imaging Markers in SPMS

Who this might be right for
Secondary Progressive Multiple SclerosisMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis
University of Utah 11
Not applicableStudy completedNCT05301335
What this trial is testing

Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study

Who this might be right for
Neurogenic BladderSpinal Cord Injuries (Complete and Incomplete)Stroke+1 more
SpineX Inc. 126
Not applicableStudy completedNCT05352971
What this trial is testing

Validation of Ella Platform for Serum Nfl And GFAP Measures In Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Centre Hospitalier Universitaire de Nīmes 664
Large-scale testing (Phase 3)Ended earlyNCT01047319
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 1,047
Large-scale testing (Phase 3)Study completedNCT01707992
What this trial is testing

The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 2,199
Testing effectiveness (Phase 2)WithdrawnNCT01086371
What this trial is testing

Rhythmic Auditory Stimulation and Walking Performance in Multiple Sclerosis (MS) Patients

Who this might be right for
Gait Disturbance in Multiple Sclerosis Patients
The Cleveland Clinic
Testing effectiveness (Phase 2)Study completedNCT00228163
What this trial is testing

Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses

Who this might be right for
Multiple Sclerosis
Sanofi 147
Load More Results